Biointron

company

About

Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents.

  • Shanghai,Shanghai,China
  • 251 - 500

Details

Last Funding Type
Series B
Last Funding Money Raised
¥500M
Industries
Biotechnology,Health Care,Medical
Founded date
Jan 1, 2012
Number Of Employee
251 - 500
Operating Status
Active
Legal Name
Biointron Biological Inc.

Biointron is committed to providing high-quality and economic recombinant protein/antibody reagents. The company was founded in 2012 and is headquartered in Shanghai, China.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
¥500M
Biointron has raised a total of ¥500M in funding over 2 rounds. Their latest funding was raised on Sep 2, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 2, 2022 Series B ¥500M 13 Detail
Jul 28, 2021 Series A 1 Detail

Investors

Number of Lead Investors
Number of Investors
13
Biointron is funded by 13 investors. West Shanghai Group and Joy Time are the most recent investors.
Investor Name Lead Investor Funding Round
West Shanghai Group Series B
Joy Time Series B
Jifeng Ventures Series B
ALAN AMC Series B
BeFor Capital Series B
Co-Stone Venture Capital Series B
CS Capital Series B
Furong Capital Series B
Gaorong Capital Series B
GOVTOR Series B